Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

108 та иш

Иш: Natural killer cell-mediated immune surveillance in cancer: Role of tumor microenvironment

  1. Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications

    Nida Iqbal, Nida Iqbal, Naveed Iqbal +1

    Шарҳ мақола20146 иқтибос
    ABI
  2. Roles of the immune system in cancer: from tumor initiation to metastatic progression

    Hugo González, Catharina Hagerling, Zena Werb

    Шарҳ мақола20184 иқтибос
    ABI
  3. Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

    Douglas Hanahan, Lisa M. Coussens

    Шарҳ мақола20124 иқтибос
    ABI
  4. The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy

    Sourav Paul, Girdhari Lal

    Шарҳ мақола20173 иқтибос
    ABI
  5. Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors

    Ombretta Melaiu, Valeria Lucarini, Loredana Cifaldi +1

    Шарҳ мақола20203 иқтибос
    ABI
  6. Natural killer cells in cancer biology and therapy

    Song‐Yang Wu, Tong‐Ming Fu, Yi‐Zhou Jiang +1

    Шарҳ мақола20203 иқтибос
    ABI
  7. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation

    Karthik Dhatchinamoorthy, Jeff D. Colbert, Kenneth L. Rock

    Шарҳ мақола20213 иқтибос
    ABI
  8. Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer

    Bihui Cao, Manting Liu, Jingjun Huang +17

    Мақола20213 иқтибос
    ABI
  9. Mechanisms of Tumor Cell–Intrinsic Immune Evasion

    Stefani Spranger, Thomas F. Gajewski

    Мақола20172 иқтибос
    ABI
  10. Natural killer cell cytotoxicity and its regulation by inhibitory receptors

    Santosh Kumar

    Шарҳ мақола20182 иқтибос
    ABI
  11. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications

    Simona Sivori, Paola Vacca, Genny Del Zotto +3

    Шарҳ мақола20192 иқтибос
    ABI
  12. Transforming Growth Factor-β Signaling in Immunity and Cancer

    Eduard Batlle, Joan Massagué

    Шарҳ мақола20192 иқтибос
    ABI
  13. The Tumor Microenvironment—A Metabolic Obstacle to NK Cells’ Activity

    Joanna Domagała, Mieszko Lachota, Marta Kłopotowska +5

    Шарҳ мақола20202 иқтибос
    ABI
  14. Interleukin-2 therapy of cancer-clinical perspectives

    Jamal Majidpoor, Keywan Mortezaee

    Шарҳ мақола20212 иқтибос
    ABI
  15. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer

    Kai Li, Houhui Shi, Benxia Zhang +6

    Шарҳ мақола20212 иқтибос
    ABI
  16. Targeting TGF-β signal transduction for fibrosis and cancer therapy

    Dandan Peng, Minyang Fu, Manni Wang +2

    Шарҳ мақола20222 иқтибос
    ABI
  17. The Next Generation of Cellular Immunotherapy: Chimeric Antigen Receptor-Natural Killer Cells

    Jake Moscarelli, David J. Zahavi, Rachael Maynard +1

    Шарҳ мақола20222 иқтибос
    ABI
  18. Immunotherapy of targeting MDSCs in tumor microenvironment

    Hongshu Sui, Shengyi Dongye, Xiaocui Liu +11

    Шарҳ мақола20222 иқтибос
    ABI
  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI
  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI
  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI
  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI
  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI